An ounce of caution

Superparamagnetic iron oxide nanoparticles are increasingly used alternatives to gadolinium-based magnetic resonance imaging (MRI) contrast agents in the diagnosis of osteomyelitis in diabetic patients with renal failure.1 Ferumoxytol is approved by the United States Food and Drug Administration and the European Medicines Agency for intravenous use for iron replacement therapy.1 –3 Ferumoxytol is composed of an iron–carbohydrate complex that minimizes dissociation and appearance of free iron into the serum.
Source: Annals of Allergy, Asthma and Immunology - Category: Allergy & Immunology Authors: Tags: Letters Source Type: research